EMIS appoints new MD and announces agreement with NHS Wales

NHS Wales has entered into an agreement, which has a maximum value of £7.6m, with Leeds-based healthcare company EMIS Group’s subsidiary, Ascribe.

The maximum value of the framework agreement, which is to provide a clinical solution to manage unscheduled care in Wales, is approximately £7.6m over the seven-year initial term of the contract, and includes software and hardware, as well as implementation services and ongoing support and maintenance. There is also an option to extend the agreement for a further four years... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...